• Roche Global
  • Roche New Zealand
Roche
Roche
  • Home
  • Cancer Type
    • Breast Cancer
      • Symptoms & Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Bowel Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Skin Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Blood Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Lung Cancer
      • Symptoms and Diagnosis
      • Standard treatments
      • Targeted Therapies
      • Sources of Further Information
    • Cervical Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Ovarian Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Brain Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Stomach Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
  • Treatments
    • Avastin
      • Avastin for Brain Cancer
      • Avastin for Bowel Cancer
      • Avastin for Cervical Cancer
      • Avastin for Lung Cancer
      • Avastin for Ovarian Cancer
    • Gazyva
      • Gazyva for First-Line Chronic Lymphocytic Leukaemia
    • Herceptin
      • Herceptin for Early Breast Cancer
      • Herceptin for Metastatic Breast Cancer
      • Herceptin for Stomach Cancer
    • Kadcyla
      • Kadcyla for Metastatic Breast Cancer
    • MabThera
      • MabThera for Second-Line or Relapsed Chronic Lymphocytic Leukaemia
      • MabThera as a Maintenance Treatment for Follicular Lymphoma
    • Perjeta
      • Perjeta for Early Breast Cancer
      • Perjeta for Metastatic Breast Cancer
    • Tarceva
      • Tarceva for Lung Cancer
    • TECENTRIQ
      • TECENTRIQ for Lung Cancer
    • Zelboraf
      • Zelboraf for Skin Cancer
  • Accessing Treatment
    • Funding and Cost Share Programmes
    • Private Providers
    • Understand how Medicines are Made Available for Kiwis
  • Latest Articles
    • Foundation Medicine
    • Metastatic Melanoma - do you know all your options?
    • Breast Cancer in New Zealand
    • Understanding how medicines are made available to New Zealanders
    • Targeted treatment options bring new hope to cancer patients
    • New multi-medicine agreement with Pharmac
    • What you need to know about bowel cancer
    • New private cancer clinic opened in Tauranga
    • First Private Cancer Care Centre Opens In Wellington
    • If you have early breast cancer, this is important news for you.
Roche
  • Home
  • Cancer Type
    • Breast Cancer
      • Symptoms & Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Bowel Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Skin Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Blood Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Lung Cancer
      • Symptoms and Diagnosis
      • Standard treatments
      • Targeted Therapies
      • Sources of Further Information
    • Cervical Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Ovarian Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Brain Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
    • Stomach Cancer
      • Symptoms and Diagnosis
      • Standard Treatments
      • Targeted Therapies
      • Sources of Further Information
  • Treatments
    • Avastin
      • Avastin for Brain Cancer
      • Avastin for Bowel Cancer
      • Avastin for Cervical Cancer
      • Avastin for Lung Cancer
      • Avastin for Ovarian Cancer
    • Gazyva
      • Gazyva for First-Line Chronic Lymphocytic Leukaemia
    • Herceptin
      • Herceptin for Early Breast Cancer
      • Herceptin for Metastatic Breast Cancer
      • Herceptin for Stomach Cancer
    • Kadcyla
      • Kadcyla for Metastatic Breast Cancer
    • MabThera
      • MabThera for Second-Line or Relapsed Chronic Lymphocytic Leukaemia
      • MabThera as a Maintenance Treatment for Follicular Lymphoma
    • Perjeta
      • Perjeta for Early Breast Cancer
      • Perjeta for Metastatic Breast Cancer
    • Tarceva
      • Tarceva for Lung Cancer
    • TECENTRIQ
      • TECENTRIQ for Lung Cancer
    • Zelboraf
      • Zelboraf for Skin Cancer
  • Accessing Treatment
    • Funding and Cost Share Programmes
    • Private Providers
    • Understand how Medicines are Made Available for Kiwis
  • Latest Articles
    • Foundation Medicine
    • Metastatic Melanoma - do you know all your options?
    • Breast Cancer in New Zealand
    • Understanding how medicines are made available to New Zealanders
    • Targeted treatment options bring new hope to cancer patients
    • New multi-medicine agreement with Pharmac
    • What you need to know about bowel cancer
    • New private cancer clinic opened in Tauranga
    • First Private Cancer Care Centre Opens In Wellington
    • If you have early breast cancer, this is important news for you.
Accessing Treatment
You are here: Home / Accessing Treatment
mobile-accessingtreatment.jpg
  • Accessing Treatment

    Accessing Treatment

Learn How to Access Treatment in New Zealand

Roche New Zealand has a number of Cost Share Programmes designed to help reduce the cost of medicines which are not funded by the government’s drug buying agency, PHARMAC. The following pages explain how medicines are made available to Kiwi’s, how to privately pay for medicines, a list of private treatment centres and how Roche Cost Share Programmes might be able to offer assistance with the cost of your medicine.

There may be Roche
funding options
available to you
Learn More
You can pay for
your treatment
privately.
Find out More
Looking for a
private provider
for treatment
Start here
Understand how
medicines are made
available for Kiwis
Learn More
  • Roche Global
  • Roche New Zealand
  • Privacy Statement
  • Legal Statement

© 2017 Roche Products (New Zealand) Limited. For more information please visit www.medsafe.govt.nz. Access to this site is subject to the terms in our Legal Statement. You accept these terms by continuing to access this site. This site was last updated on March 2016. ID2231/TAPS NA8256/2016MAR. Spitfire J000084